![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
新的临床风险分层和治疗策略在复发/耐药的外围T细胞淋巴瘤中
Esther Wei Yin Chang1,2, Ya Hwee Tan3,4, Jason Yongsheng Chan5,6,7
1Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. esther.chang.w.y@singhealth.com.sg.
Journal of hematology & oncology
|June 2, 2024
概括
周围T细胞淋巴瘤 (PTCL) 难以治疗. 本综述涵盖不断发展的预后指数和新疗法,包括免疫调节剂和激酶抑制剂,以改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一组复杂的血液癌症,预后不佳.
- 目前的治疗策略通常涉及组合化疗,但新药正在出现.
研究的目的:
- 审查PTCL风险分层的临床预后指数的进展.
- 为PTCL提供了当前和新兴治疗场景的全面概述.
主要方法:
- 对PTCL的临床预后指数和治疗策略的文献综述.
- 在早期临床研究中分析新的向药物和途径.
主要成果:
- 在过去的二十年中,PTCL的临床预后指数已经发展.
- 现在可以获得广泛的治疗场景,包括针对前线和救援环境的向药物.
结论:
- 进一步了解PTCL分子病理生物学正在推动创新的治疗方法.
- 像免疫调节剂,表观遗传疗法和激酶抑制剂这样的新方法显示出有前途.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.1K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514